Compare
Pit 2–4 stocks against each other: U-Score, pillars, fundamentals, and normalized price history. Same universe, same methodology, one view.
| Metric | ZIMLAB Zim Laboratories Limited Pharma · Small | MEDICO Medico Remedies Limited Pharma · Small | VALIANTLAB Valiant Laboratories Limited Pharma · Small | NECLIFE Nectar Lifesciences Limited Pharma · Small |
|---|---|---|---|---|
| Final Score | 21 | 52 | 15 | 28 |
| Verdict | OVERVALUED | FAIR VALUE | OVERVALUED | OVERVALUED |
| Style | OVERVALUED | Financial Turnaround | OVERVALUED | OVERVALUED |
| Piotroski | 6/9 | 8/9 | 4/9 | 4/9 |
| Valuation | 4/30 | 8/30 | 3/30 | 5/30 |
| Growth | 3/25 | 14/25 | 2/25 | 4/25 |
| Quality | 0/20 | 14/20 | 0/20 | 0/20 |
| Balance Sheet | 7/15 | 10/15 | 11/15 | 11/15 |
| Cash Flow | 4/10 | 4/10 | 1/10 | 9/10 |
| Price | ₹113.05 | ₹43.42 | ₹72.82 | ₹11.83 |
| P/E | 133.00 | 27.60 | 72.40 | — |
| P/B | 1.95 | 4.80 | 1.25 | 0.39 |
| ROE | 1.59% | 19.00% | 2.00% | -7.46% |
| ROCE | 4.76% | 23.10% | 2.54% | -4.88% |
| Debt / Equity | 0.43 | 0.25 | 0.00 | 0.00 |
| FCF Yield | — | 0.28% | — | 380.09% |
| Dividend Y | — | — | — | — |
| Altman Z | 3.14 | 5.25 | 5.48 | 4.68 |
| Promoter % | 30.35% | 61.38% | 74.94% | 51.84% |
| Mkt Cap (₹Cr) | 577.00 | 362.00 | 402.00 | 226.00 |
| Graham # | ₹36.86 | ₹17.99 | ₹36.77 | — |
| Fair PE | 2.8 | 42.0 | 1.7 | 5.8 |
| MoS % | -3604.3% | +34.6% | -4074.8% | — |
Normalized price (3-year, indexed to 100)
Higher line = better relative performance from startZIMLAB99
MEDICO75
VALIANTLAB64
NECLIFE32